HEADER TRANSFERASE 19-NOV-10 2XYU TITLE CRYSTAL STRUCTURE OF EPHA4 KINASE DOMAIN IN COMPLEX WITH VUF 12058 COMPND MOL_ID: 1; COMPND 2 MOLECULE: EPHRIN TYPE-A RECEPTOR 4,; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: KINASE DOMAIN, RESIDUES 1548-1832; COMPND 5 SYNONYM: EPHA4, TYROSINE-PROTEIN KINASE RECEPTOR MPK-3, TYROSINE- COMPND 6 PROTEIN KINASE RECEPTOR SEK-1; COMPND 7 EC: 2.7.10.1; COMPND 8 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: MUS MUSCULUS; SOURCE 3 ORGANISM_COMMON: MOUSE; SOURCE 4 ORGANISM_TAXID: 10090; SOURCE 5 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 6 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 7 EXPRESSION_SYSTEM_STRAIN: BL21(DE3); SOURCE 8 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 9 EXPRESSION_SYSTEM_PLASMID: PET28AKDONLY KEYWDS SIGNALING PROTEIN, TRANSFERASE EXPDTA X-RAY DIFFRACTION AUTHOR C.J.A.FARENC,P.H.N.CELIE,O.P.J.VANLINDEN,G.SIEGAL REVDAT 5 20-DEC-23 2XYU 1 REMARK REVDAT 4 01-FEB-12 2XYU 1 JRNL REVDAT 3 25-JAN-12 2XYU 1 DBREF REVDAT 2 28-DEC-11 2XYU 1 JRNL REVDAT 1 30-NOV-11 2XYU 0 JRNL AUTH O.P.VAN LINDEN,C.J.A.FARENC,W.H.ZOUTMAN,L.HAMEETMAN, JRNL AUTH 2 M.WIJTMANS,R.LEURS,C.P.TENSEN,G.SIEGAL,I.J.DE ESCH JRNL TITL FRAGMENT BASED LEAD DISCOVERY OF SMALL MOLECULE INHIBITORS JRNL TITL 2 FOR THE EPHA4 RECEPTOR TYROSINE KINASE. JRNL REF EUR.J.MED.CHEM. V. 47 493 2012 JRNL REFN ISSN 0223-5234 JRNL PMID 22137457 JRNL DOI 10.1016/J.EJMECH.2011.11.020 REMARK 2 REMARK 2 RESOLUTION. 2.12 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX (PHENIX.REFINE) REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : ML REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.12 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 43.19 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 93.2 REMARK 3 NUMBER OF REFLECTIONS : 16232 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.192 REMARK 3 R VALUE (WORKING SET) : 0.189 REMARK 3 FREE R VALUE : 0.230 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.100 REMARK 3 FREE R VALUE TEST SET COUNT : 822 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 43.1957 - 3.8457 0.98 2844 166 0.1934 0.2301 REMARK 3 2 3.8457 - 3.0527 0.98 2689 160 0.1560 0.1820 REMARK 3 3 3.0527 - 2.6669 0.95 2600 135 0.1753 0.2354 REMARK 3 4 2.6669 - 2.4231 0.93 2550 123 0.1914 0.2370 REMARK 3 5 2.4231 - 2.2494 0.90 2426 132 0.2191 0.2802 REMARK 3 6 2.2494 - 2.1168 0.85 2301 106 0.2589 0.3249 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : FLAT BULK SOLVENT MODEL REMARK 3 SOLVENT RADIUS : 1.11 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : 0.40 REMARK 3 B_SOL : 60.01 REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.230 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 21.640 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 20.96 REMARK 3 MEAN B VALUE (OVERALL, A**2) : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -1.31330 REMARK 3 B22 (A**2) : -2.23300 REMARK 3 B33 (A**2) : 3.54630 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.009 2127 REMARK 3 ANGLE : 1.024 2862 REMARK 3 CHIRALITY : 0.068 309 REMARK 3 PLANARITY : 0.004 355 REMARK 3 DIHEDRAL : 12.211 789 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 2XYU COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 19-NOV-10. REMARK 100 THE DEPOSITION ID IS D_1290046203. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 29-AUG-10 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 5.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : ESRF REMARK 200 BEAMLINE : ID23-2 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.8726 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : MIRROR REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : MARMOSAIC 225 MM CCD REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : XDS REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 17378 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.120 REMARK 200 RESOLUTION RANGE LOW (A) : 43.190 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 6.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.5 REMARK 200 DATA REDUNDANCY : 3.600 REMARK 200 R MERGE (I) : 0.14000 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 8.5000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.12 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.23 REMARK 200 COMPLETENESS FOR SHELL (%) : 98.2 REMARK 200 DATA REDUNDANCY IN SHELL : 3.60 REMARK 200 R MERGE FOR SHELL (I) : 0.69000 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 1.900 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: AMORE REMARK 200 STARTING MODEL: PDB ENTRY 2Y6M REMARK 200 REMARK 200 REMARK: NONE REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 45.77 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.27 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: AMMONIUM SULFATE, BISTRIS PH 5.5, PEG REMARK 280 10K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 16.27200 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 48.97950 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 45.77250 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 48.97950 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 16.27200 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 45.77250 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A 766 REMARK 465 MET A 767 REMARK 465 SER A 768 REMARK 465 ARG A 769 REMARK 465 VAL A 770 REMARK 465 LEU A 771 REMARK 465 GLU A 772 REMARK 465 ASP A 773 REMARK 465 ASP A 774 REMARK 465 PRO A 775 REMARK 465 GLU A 776 REMARK 465 ALA A 777 REMARK 465 ALA A 778 REMARK 465 TYR A 779 REMARK 465 THR A 780 REMARK 465 THR A 781 REMARK 465 ARG A 782 REMARK 465 GLY A 783 REMARK 465 GLY A 784 REMARK 465 LYS A 785 REMARK 465 GLY A 892 REMARK 465 SER A 893 REMARK 465 GLU A 894 REMARK 465 SER A 895 REMARK 465 SER A 896 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 GLU A 624 OE1 REMARK 470 GLU A 631 OE1 REMARK 470 ARG A 639 CZ NH1 NH2 REMARK 470 LYS A 641 CE NZ REMARK 470 ARG A 646 CG CD NE CZ NH1 NH2 REMARK 470 LYS A 662 CE NZ REMARK 470 GLU A 670 OE1 REMARK 470 ARG A 717 NE CZ NH1 NH2 REMARK 470 ILE A 786 CB CG1 CG2 CD1 REMARK 470 ARG A 799 NE CZ NH1 NH2 REMARK 470 GLU A 838 CG CD OE1 OE2 REMARK 470 LYS A 889 CG CD CE NZ REMARK 470 ARG A 890 CG CD NE CZ NH1 NH2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 GLU A 624 -60.14 -106.92 REMARK 500 ARG A 745 -19.41 80.15 REMARK 500 SER A 763 -157.19 -125.63 REMARK 500 ASP A 764 64.04 61.91 REMARK 500 TRP A 826 -125.78 51.83 REMARK 500 ASN A 884 69.50 -119.18 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE GOL A 1892 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE GOL A 1893 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE GOL A 1894 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE GOL A 1895 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC5 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE GOL A 1896 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC6 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE GOL A 1897 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC7 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE Q9G A 1898 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1B0X RELATED DB: PDB REMARK 900 THE CRYSTAL STRUCTURE OF AN EPH RECEPTOR SAM DOMAIN REVEALS A REMARK 900 MECHANISM FOR MODULAR DIMERIZATION. DBREF 2XYU A 612 896 UNP Q03137 EPHA4_MOUSE 612 896 SEQRES 1 A 285 PHE ALA LYS GLU ILE ASP ALA SER CYS ILE LYS ILE GLU SEQRES 2 A 285 LYS VAL ILE GLY VAL GLY GLU PHE GLY GLU VAL CYS SER SEQRES 3 A 285 GLY ARG LEU LYS VAL PRO GLY LYS ARG GLU ILE CYS VAL SEQRES 4 A 285 ALA ILE LYS THR LEU LYS ALA GLY TYR THR ASP LYS GLN SEQRES 5 A 285 ARG ARG ASP PHE LEU SER GLU ALA SER ILE MET GLY GLN SEQRES 6 A 285 PHE ASP HIS PRO ASN ILE ILE HIS LEU GLU GLY VAL VAL SEQRES 7 A 285 THR LYS CYS LYS PRO VAL MET ILE ILE THR GLU TYR MET SEQRES 8 A 285 GLU ASN GLY SER LEU ASP ALA PHE LEU ARG LYS ASN ASP SEQRES 9 A 285 GLY ARG PHE THR VAL ILE GLN LEU VAL GLY MET LEU ARG SEQRES 10 A 285 GLY ILE GLY SER GLY MET LYS TYR LEU SER ASP MET SER SEQRES 11 A 285 TYR VAL HIS ARG ASP LEU ALA ALA ARG ASN ILE LEU VAL SEQRES 12 A 285 ASN SER ASN LEU VAL CYS LYS VAL SER ASP PHE GLY MET SEQRES 13 A 285 SER ARG VAL LEU GLU ASP ASP PRO GLU ALA ALA TYR THR SEQRES 14 A 285 THR ARG GLY GLY LYS ILE PRO ILE ARG TRP THR ALA PRO SEQRES 15 A 285 GLU ALA ILE ALA TYR ARG LYS PHE THR SER ALA SER ASP SEQRES 16 A 285 VAL TRP SER TYR GLY ILE VAL MET TRP GLU VAL MET SER SEQRES 17 A 285 TYR GLY GLU ARG PRO TYR TRP ASP MET SER ASN GLN ASP SEQRES 18 A 285 VAL ILE LYS ALA ILE GLU GLU GLY TYR ARG LEU PRO PRO SEQRES 19 A 285 PRO MET ASP CYS PRO ILE ALA LEU HIS GLN LEU MET LEU SEQRES 20 A 285 ASP CYS TRP GLN LYS GLU ARG SER ASP ARG PRO LYS PHE SEQRES 21 A 285 GLY GLN ILE VAL ASN MET LEU ASP LYS LEU ILE ARG ASN SEQRES 22 A 285 PRO ASN SER LEU LYS ARG THR GLY SER GLU SER SER HET GOL A1892 6 HET GOL A1893 6 HET GOL A1894 6 HET GOL A1895 6 HET GOL A1896 6 HET GOL A1897 6 HET Q9G A1898 22 HETNAM GOL GLYCEROL HETNAM Q9G 5-(5-FLUORO-2-METHYLPHENYL)-6,7,8,9-TETRAHYDRO-3H- HETNAM 2 Q9G PYRAZOLO[3,4-C]ISOQUINOLIN-1-AMINE HETSYN GOL GLYCERIN; PROPANE-1,2,3-TRIOL FORMUL 2 GOL 6(C3 H8 O3) FORMUL 8 Q9G C17 H17 F N4 FORMUL 9 HOH *136(H2 O) HELIX 1 1 ASP A 617 SER A 619 5 3 HELIX 2 2 THR A 660 GLY A 675 1 16 HELIX 3 3 SER A 706 LYS A 713 1 8 HELIX 4 4 THR A 719 MET A 740 1 22 HELIX 5 5 ALA A 748 ARG A 750 5 3 HELIX 6 6 PRO A 787 THR A 791 5 5 HELIX 7 7 ALA A 792 ARG A 799 1 8 HELIX 8 8 THR A 802 SER A 819 1 18 HELIX 9 9 SER A 829 GLU A 839 1 11 HELIX 10 10 PRO A 850 TRP A 861 1 12 HELIX 11 11 GLU A 864 ARG A 868 5 5 HELIX 12 12 LYS A 870 ASN A 884 1 15 HELIX 13 13 PRO A 885 LYS A 889 5 5 SHEET 1 AA 5 ILE A 621 GLY A 630 0 SHEET 2 AA 5 GLY A 633 LEU A 640 -1 O GLY A 633 N GLY A 630 SHEET 3 AA 5 ILE A 648 LEU A 655 -1 O ILE A 648 N LEU A 640 SHEET 4 AA 5 MET A 696 GLU A 700 -1 O ILE A 697 N LYS A 653 SHEET 5 AA 5 LEU A 685 VAL A 689 -1 N GLU A 686 O ILE A 698 SHEET 1 AB 2 ILE A 752 VAL A 754 0 SHEET 2 AB 2 CYS A 760 VAL A 762 -1 O LYS A 761 N LEU A 753 CISPEP 1 LYS A 693 PRO A 694 0 1.36 SITE 1 AC1 9 PHE A 718 VAL A 720 MET A 818 TYR A 820 SITE 2 AC1 9 ASP A 848 ASN A 884 HOH A2091 HOH A2104 SITE 3 AC1 9 HOH A2132 SITE 1 AC2 4 TYR A 742 VAL A 743 HOH A2133 HOH A2134 SITE 1 AC3 5 ARG A 842 LEU A 858 TRP A 861 GLN A 862 SITE 2 AC3 5 HOH A2135 SITE 1 AC4 5 LYS A 656 ALA A 657 GLY A 658 TYR A 659 SITE 2 AC4 5 HIS A 854 SITE 1 AC5 4 ARG A 789 ARG A 823 SER A 829 ASN A 830 SITE 1 AC6 4 CYS A 692 LYS A 693 ASP A 832 LYS A 835 SITE 1 AC7 11 ALA A 651 LYS A 653 MET A 674 THR A 699 SITE 2 AC7 11 GLU A 700 TYR A 701 MET A 702 LEU A 753 SITE 3 AC7 11 SER A 763 ASP A 764 HOH A2136 CRYST1 32.544 91.545 97.959 90.00 90.00 90.00 P 21 21 21 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.030728 0.000000 0.000000 0.00000 SCALE2 0.000000 0.010924 0.000000 0.00000 SCALE3 0.000000 0.000000 0.010208 0.00000